Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.

Therapy 52

Therapy Treatment Clinical Trials Access 52

Cannabis Law Report

JUNE 9, 2022

Decriminalisation in the ACT but still illegal to do TGA-approved psychedelic therapy. The substances in clinical settings are unadulterated, the dosing levels are controlled, patients can’t take the substances home and patients are screened to ensure that they have no contraindications. Here’s what they say.

Therapy 52

Therapy Medicine Recreational Decriminalization 52

MMJ Recs

MARCH 28, 2024

Navigating the world of medical marijuana (MMJ) in Iowa can be a daunting task for patients seeking alternative treatments. From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey.

Patients 52

Patients Treatment Research and Development Therapy 52

NORML

FEBRUARY 13, 2019

Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.

Legislation 230

Legislation Access Chronic Pain Marijuana 230

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

NORML

NOVEMBER 8, 2019

This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us. Research published in the Journal of Psychoactive Drugs found a 75% reduction in Clinician-Administered Posttraumatic Scale scores following cannabis therapy.

Access 204

Access Marijuana Treatment Legislation 204

Cannabis Law Report

JULY 13, 2022

Physicians and researchers are urging New Mexico legislators to allow the use of psychedelic mushrooms in mental health therapy aimed at overcoming depression, anxiety, psychological trauma and alcoholism. The Democratic-led Legislature convenes its next regular session in January 2023.

Therapy 52

Therapy Legislation Access Decriminalization 52

Veriheal

MARCH 23, 2022

Bronner’s expressed gratitude and excitement for its new partnership with healthcare organization Enthea to expand its employee medical benefits to include psychedelic therapies. Why Psychedelic Therapies? Enthea reports many astounding statistics surrounding psychedelic-assisted therapy studies.

Therapy 95

Therapy Treatment Supply Chain Pharmaceutical 95

Cannabis Law Report

FEBRUARY 14, 2022

Our families and communities are suffering, and we urgently need access to preventative and curative medicines and medical care that is safe and effective. These ground-breaking treatments offer therapeutic access to either psilocybin (the active ingredient in ‘magic mushrooms’) or MDMA, a synthetic medicine.

Medicine 52

Medicine Access Therapy Treatment 52

Cannabis Law Report

APRIL 4, 2022

Congress, signed into law by President Trump, with 41 state enactments, give terminally ill patients access to experimental medicines still in development? But the Drug Enforcement Agency is barring access to one such experimental medicine: psilocybin, also known in its fungal form as “magic mushrooms.”.

Access 52

Access Patients DEA Research and Development 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

MMJ Recs

MAY 23, 2024

We will be exploring cannabis therapy for chronic conditions. From alleviating symptoms to offering long-term relief, the exploration of cannabis therapy for chronic conditions is becoming increasingly pertinent in medical discourse. Typically, it can last for weeks, months, or even years.

Conditions 105

Conditions Chronic Pain Therapy Marijuana 105

Cannabis Law Report

DECEMBER 5, 2021

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Veriheal

MAY 26, 2022

But one area of cannabis medicine is still lagging behind—research. Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. RoC also works to increase patients’ access to medical cannabis by helping U.S.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Cannabis Law Report

MAY 29, 2022

ACT government considers Mind Medicine Australia reform to allow psychedelics. The ACT government is considering legislation changes to allow MDMA-assisted therapy to treat post-traumatic stress disorder and psilocybin to treat depression. The Canberra Times reports.

Medicine 52

Medicine Therapy Treatment Legislation 52

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? Also, a recent systematic review of healthcare professionals’ “cannabis knowledge” reported “there was a unanimous lack of self-perceived knowledge surrounding all aspects of medicinal cannabis” (2). million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Veriheal

JANUARY 18, 2024

Cannabis nurses are crucial in bridging the gap between traditional healthcare and emerging cannabis therapies. Patient education is their primary focus, as they provide knowledgeable guidance on the therapeutic benefits and potential risks of cannabis. They also seamlessly integrate this knowledge into everyday patient care.

Education 113

Education Therapy Patients Research and Development 113

Veriheal

JUNE 21, 2023

There will also be measures put in place to control therapeutic access to psilocybin while awaiting federal reform. If approved by the Food and Drug Administration (FDA), this psychedelic would be used to treat chronic and life-threatening mental disorders, especially for patients with limited access to effective treatments.

Access 97

Access Legalization Research and Development Legislation 97

MMJ Recs

JANUARY 16, 2023

Read on to discover some of the best pain management centers in West Virginia that MMJ patients should know about. Pain management doctors in West Virginia use a wide range of treatments to manage chronic pain and provide patients with an improved quality of life. Physical therapy. Physical Medicine Associates.

Chronic Pain 98

Chronic Pain Patients Treatment Medicine 98

Veriheal

JUNE 7, 2021

Note: Veriheal does not support illegally consuming therapeutic substances like MDMA but acknowledges that it transpires because of the current illicit status of both, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Therapy 82

Therapy Treatment Conditions Clinical Trials 82

Cannabis Law Report

AUGUST 19, 2021

Cantourage has successfully partnered with Australian-based Cannim, the leading cultivator of medicinal cannabis in Jamaica. Cannim will sell its products in the EU medical markets through the Cantourage Fast Track Access Platform. Cantourage continues to provide innovative cultivars and a safe, diverse supply for patients”.

Access 98

Access Cultivation Patients Indica 98

Cannabis Law Report

JUNE 5, 2021

Forbes report… A young boy and his single mother are in the midst of a 1,000-mile walk across the United Kingdom, a journey they are making to raise awareness and funds to provide medicinal cannabis to chronically ill patients. The walk is also serving as a call to action for the U.K. The Boy Who Changed The Law.

Access 104

Access Epilepsy Therapy Medicine 104

Cannabis Law Report

OCTOBER 22, 2021

(TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce that following discussions with the U.K. The ILAP accelerates time to market and facilitates patient access to emerging and novel treatments.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. About Curaleaf International.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

MAY 25, 2022

May 25, 2022 – SACRAMENTO – Senator Scott Wiener (D-San Francisco)’s Senate Bill 1186 , which restores voter-created access to medicinal cannabis across the state by requiring cities to provide patients access to purchase medicinal cannabis by delivery, passed the Senate with a unanimous bipartisan vote.

Medicine 52

Medicine Legislation Chronic Pain Access 52

Cannabis Law Report

FEBRUARY 28, 2022

Bronner’s, Partners with Pioneering Health Plan Administrator, Enthea, to Provide Psychedelic Therapy as Employee Healthcare Benefit. Leading US Company to Offer Employee Coverage for Ketamine Assisted Therapy to Promote Mental Health. First Ever Partnership Between Health Plan Administrator and.

Therapy 52

Therapy Treatment Research and Development Advocacy 52

MMJ Recs

MAY 29, 2024

The perception and legalization of marijuana for medicinal use have undergone a significant shift across the United States. This program allows individuals with qualifying medical conditions to access marijuana for therapeutic purposes upon obtaining a medical marijuana card.

Marijuana 52

Marijuana Programs Patients Conditions 52

Cannabis Law Report

FEBRUARY 27, 2022

Melbourne-based medicinal cannabis product developer Incannex (ASX: IHL) has officially landed on the US stock exchange Nasdaq, hoping its dual listing will attract an expanded pool of investors. Food and Drug Administration approval for all of our therapies and to bringing these innovative medicines to patients in need.”.

Medicine 52

Medicine Research and Development Therapy Pharmaceutical 52

Cannabis Law Report

JANUARY 26, 2022

MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021. The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

JUNE 23, 2022

SACRAMENTO – Senator Scott Wiener’s (D-San Francisco) Senate Bill 1186, which restores voter-created access to medicinal cannabis across the state by requiring cities to allow patients access to purchase legal medicinal cannabis by delivery, passed the Assembly Business and Professions Committee by a vote of 13-2.

Medicine 52

Medicine Legislation Chronic Pain Business 52

Veriheal

FEBRUARY 18, 2021

But it’s acknowledged that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. The university has conducted research that studied the best music to include in psychedelic therapy. What is Psychedelic Therapy.

Therapy 52

Therapy Research and Development Collective Consumption 52

Cannabis Law Report

APRIL 23, 2022

April 23, 2022 – SACRAMENTO – Senator Scott Wiener (D-San Francisco)’s Senate Bill 1186 , which restores voter-created access to medicinal cannabis across the state by requiring cities to provide patients access to purchase medicinal cannabis by delivery, passed the Senate Governance and Finance Committee by a vote of 4-1.

Medicine 52

Medicine Legislation Chronic Pain Access 52

Veriheal

JUNE 20, 2023

In a recent 2023 study , scientists have developed two promising drug candidates for treating these conditions, drawing inspiration from a traditional African psychedelic plant medicine called ibogaine. Always consult a physician before attempting alternative therapies.

Medicine 98

Medicine Research and Development Treatment Conditions 98

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition. In 1996, the state became the first in the U.S.

Dispensary 52

Dispensary Patients Environment Conditions 52

Americans for Safe Access

JULY 29, 2020

Oregon is one of the few but growing number of states that have both a medical cannabis program and an adult use (recreational) program, and users of cannabis medicine can be found in either group. A big thank you to Debbie for her time and to ASA for all that they do.

Programs 169

Programs Therapy Medicine Patients 169

Puff Puff Post

JUNE 5, 2019

The “sacred” plant, as many of our ancestors referred to it, has traditionally been used as a first line of therapy in various parts of the world. For most cultures, the use of cannabis as a medicine can be traced back to thousands of years ago. For the Chinese , early uses have been reported dating back to 2700 B.C.,

Medicine 96

Medicine Patients Cannabinoids Oil 96

Cannabis Law Report

AUGUST 15, 2021

As we embark on our next phase of growth, our strong syndicate of expert investors will support us in bringing much-needed innovative treatments to patients suffering from neurological and psychiatric conditions.” Beckley Psytech – www.beckleypsytech.com.

Medicine 98

Medicine Research and Development Conditions Treatment 98